VX-950HEP1001 - Drug-drug Interaction Study Between Telaprevir and Raltegravir
Clinical trial NCT01253551 · COMPLETED
Trial details
- NCT number
- NCT01253551
- Sponsor
- Tibotec BVBA
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-12-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.